Shingles Vaccine Most Cost Effective in SeniorsSullivan, Michele G
Herpes zoster vaccination among adults aged 60 years or older in the United States, 2007: Uptake of the first new vaccine to target seniors BackgroundApproximately one million new cases of shingles (herpes zoster [HZ]), a severely painful and debilitating disease caused by reactivation of varic....